NHS
AI:n luoma kuva
UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care
Raportoinut AI AI:n luoma kuva Faktatarkistettu
UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.
A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.